S&P 500
(0.10%) 5 474.84 points
Dow Jones
(0.11%) 39 154 points
Nasdaq
(0.42%) 17 792 points
Oil
(-0.20%) $80.67
Gas
(-3.66%) $2.66
Gold
(-0.77%) $2 312.80
Silver
(0.18%) $28.92
Platinum
(3.45%) $1 020.40
USD/EUR
(0.28%) $0.936
USD/NOK
(0.70%) $10.68
USD/GBP
(0.45%) $0.792
USD/RUB
(-0.27%) $87.25

实时更新: NLS Pharmaceutics AG [NLSPW]

交易所: NASDAQ 部门: Healthcare 工业: Biotechnology
最后更新时间25 Jun 2024 @ 04:00

26.67% $ 0.0399

Live Chart Being Loaded With Signals

Commentary (25 Jun 2024 @ 04:00):
Our systems believe the stock currently is overvalued by -0.53% compare to its pairs and should correct downwards.

NLS Pharmaceutics AG, a clinical-stage biopharmaceutical company, engages in the discovery and development of therapies for patients with rare and complex central nervous system disorders...

Stats
今日成交量 85
平均成交量 8 880
市值 7.74M
EPS $-0.140 ( Q4 | 2024-05-15 )
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E 0
(Sector) 42.63
(Industry) 24.32
ATR14 $0 (0.00%)
AADI -3.24%
ABCL 1.83%
ABCM 0.04%
ABEO -2.14%
ABIO -1.68%
ABOS 0.70%
ABSI 1.53%
ABUS -1.64%
ABVX -1.50%
ACAD -0.58%
ACER -17.95%
ACET -4.76%
ACGN 1.29%
ACHL -4.11%
ACHV 0.00%
ACIU -0.75%
ACLX 0.95%
ACRV -2.31%
ACST -2.90%
ACXP 1.38%
ADAG 4.64%
ADAP -4.54%
ADGI 0.87%
ADIL 1.75%
ADMA -2.13%
ADPT 0.00%
ADTX -2.08%
ADVM -3.33%
ADXN -1.60%
AEON -4.50%
AEZS -2.49%
AFMD -1.60%
AGEN -2.72%
AGIO -2.25%
AGLE 6.66%
AGTC 0.00%
AIKI 0.85%
AIMDW -13.88%
AKBA 0.02%
AKRO -3.28%
AKTX 1.05%
AKUS 0.00%
ALBO 0.00%
ALDX -2.10%
ALEC 0.69%
ALGS -0.74%
ALKS 0.50%
ALLK -9.79%
ALLO -6.04%
ALLR -0.96%
ALNA 3.16%
ALNY 2.48%
ALPN 0.02%
ALPX 0.00%
ALRN -1.33%
ALT -9.12%
ALVR 2.98%
ALXN 0.00%
ALXO -13.09%
ALZN 5.27%
AMRN -1.13%
AMTI -3.13%
ANAB 1.09%
ANEB -1.52%
ANGN 0.00%
ANIX -1.62%
ANL -6.60%
ANNX -0.11%
ANPC -3.15%
APGE -0.72%
APGN 8.48%
APGNW 30.65%
APLM -2.32%
APLS 0.32%
APLT -3.04%
APM 0.36%
APOP 0.38%
APRE 0.60%
APTO 5.98%
APTX 3.17%
APVO 0.93%
ARAV -13.39%
ARCT -5.02%
ARDS -14.23%
ARDX 0.25%
ARGX -0.90%
ARNA 0.00%
ARPO -0.90%
ARQT -0.31%
ARTL -2.50%
ARTLW 0.00%
ARVN 4.91%
ARWR -1.06%
ASLN -3.88%
ASMB -5.81%
ASND -1.55%
ATAI -1.85%
ATHA 5.39%
ATHE 0.56%
ATHX -33.50%
ATNF 4.32%
ATOS 0.97%
ATRA -1.93%
ATXI -2.78%
ATXS -0.11%
AUPH -0.99%
AURA 2.79%
AUTL -1.29%
AVBP -3.32%
AVEO 0.00%
AVIR -0.44%
AVRO -1.41%
AVTE -3.48%
AVTX -1.25%
AVXL -3.70%
AXLA 0.00%
AXSM -1.08%
AYLA 0.00%
AZRX 2.07%
BBI 2.17%
BBIO 3.66%
BCAB 5.56%
BCDA -2.23%
BCDAW -41.77%
BCEL 0.00%
BCLI 2.83%
BCRX 0.49%
BCTX 8.90%
BCTXW -16.32%
BCYC 0.75%
BDRX -4.64%
BDTX -1.81%
BEAM 1.03%
BFRA -2.91%
BGNE -2.40%
BIOR -6.15%
BIVI 3.41%
BLCM -6.68%
BLI -5.88%
BLPH 0.00%
BLRX -0.89%
BLTE -0.78%
BLU 0.03%
BLUE 0.33%
BMEA -10.40%
BMRN 0.16%
BNOX 6.22%
BNTC -0.42%
BNTX -1.58%
BOLD -12.19%
BOLT -1.24%
BPMC -0.85%
BPTH 0.00%
BPTS -13.47%
BRNS 0.00%
BRTX -3.52%
BTAI 26.44%
BTTX 50.67%
BTX 0.05%
BVXV 0.74%
BXRX 7.39%
BYSI 4.24%
CABA 1.59%
CADL -1.95%
CALA 0.00%
CALC -1.77%
CALT -1.59%
CAPR -1.72%
CARA -0.06%
CARM 13.20%
CASI -1.65%
CATB -6.97%
CBAY 0.03%
CBIO -2.65%
CBLI -7.31%
CBUS -5.67%
CCCC -5.21%
CCXI 0.00%
CDAK 0.00%
CDIO -2.18%
CDIOW 24.00%
CDMO -2.82%
CDMOP 0.04%
CDT -7.72%
CDTTW -39.60%
CDTX -1.31%
CDXC 0.20%
CDXS 7.24%
CELC -4.12%
CELU -1.00%
CELUW 11.80%
CERC -1.68%
CERE -1.21%
CERO -3.45%
CEROW -21.56%
CFRX -27.95%
CGEM -2.92%
CGEN -3.05%
CGON -1.78%
CGTX -3.98%
CHMA -6.00%
CHRS 1.27%
CINC 0.00%
CING -0.63%
CINGW 34.95%
CKPT -3.81%
CLBS -16.75%
CLDX -1.08%
CLGN 0.34%
CLLS -4.15%
CLNN 2.43%
CLNNW 0.00%
CLRB 6.27%
CLSD 0.00%
CLSN -0.68%
CLVS 0.00%
CMMB -0.98%
CMND 0.00%
CMPI 0.00%
CMPX -1.42%
CMRA 0.00%
CMRAW 33.33%
CMRX -3.47%
CNCE 0.00%
CNSP -36.62%
CNST 0.00%
CNTA -0.45%
CNTB 0.00%
CNTX -7.31%
COCP -2.00%
COEPW 32.45%
COGT -2.88%
CORT 2.78%
COYA -1.46%
CPRX -1.02%
CRBP -3.43%
CRBU -5.98%
CRDF -0.89%
CRGX -0.13%
CRIS -1.72%
CRNX -5.79%
CRSP 0.66%
CRTX 2.63%
CRVO -5.75%
CRVS 1.69%
CSBR -1.59%
CTCX -1.60%
CTIC 0.06%
CTMX -3.73%
CTNM -2.11%
CTXR 2.42%
CUE 6.57%
CVAC -4.94%
CVKD -2.85%
CWBR 2.80%
CYAD -12.96%
CYCC 9.09%
CYCCP 5.49%
CYCN -0.24%
CYT -2.27%
CYTK -2.26%
CYTO -1.83%
DARE 4.02%
DAWN -0.97%
DBTX -0.81%
DBVT 4.17%
DFFN 10.28%
DICE 0.06%
DMAC 30.71%
DNLI -1.39%
DNTH -10.31%
DOMH 2.43%
DRMA -1.68%
DRMAW -1.25%
DRNA 0.00%
DRTS 3.45%
DRTSW 0.00%
DRUG 0.95%
DSGN -2.72%
DTIL 1.99%
DYAI 12.26%
EARS -1.77%
EDIT -2.52%
EDSA 3.19%
EFTR 5.89%
EFTRW -51.85%
EIGR -9.21%
ELAB -2.84%
ELDN 8.99%
ELEV -5.81%
ELOX -5.38%
ELTX -4.26%
ELVN -4.07%
ELYM 2.23%
ENGN -1.72%
ENGNW 0.00%
ENLV 2.90%
ENOB 1.79%
ENSC 3.23%
ENTA 0.08%
ENTO -2.42%
ENTX 1.60%
ENVB 1.58%
EPIX -2.36%
EPRX -1.15%
EPZM 0.00%
EQ 0.34%
EQRX -2.09%
EQRXW 0.00%
ERAS -0.72%
ERNA 0.00%
ERYP 1.30%
ESLA 4.30%
ESLAW 16.64%
ETNB -2.42%
ETON 1.82%
ETTX 0.00%
EVAX -2.14%
EVGN 4.76%
EVLO 0.00%
EWTX -0.40%
EXAI -1.32%
EXEL 0.11%
EYEG -0.69%
EYEN 1.42%
EYPT 0.61%
FATE -9.95%
FBIO 0.85%
FBIOP -0.37%
FBLG -14.69%
FBRX -0.02%
FDMT -3.50%
FENC -1.29%
FGEN -7.27%
FHTX 6.87%
FIXX 0.77%
FMTX 0.00%
FNCH 8.87%
FOLD -1.93%
FREQ 4.76%
FRLN 0.15%
FRTX 0.00%
FSTX 0.00%
FTRE -0.36%
FULC -3.51%
FUSN 0.00%
FWBI 4.59%
FWP 0.00%
GALT -6.22%
GANX -2.31%
GBIO -2.83%
GBT 0.01%
GDTC 0.50%
GERN -4.42%
GHRS -2.30%
GLMD -5.09%
GLPG -2.15%
GLSI 1.43%
GLTO -2.16%
GLUE -2.37%
GLYC -10.15%
GMAB -0.23%
GMDA -18.25%
GMTX 0.00%
GNCA -85.71%
GNFT -3.14%
GNLX 1.33%
GNPX 0.00%
GNTA 3.94%
GOSS -10.44%
GOVX 0.91%
GOVXW -49.04%
GPCR -8.57%
GRAY -10.80%
GRCL 0.05%
GRNA -0.03%
GRNAW 8.91%
GRPH -2.75%
GRTS 1.18%
GRTX 5.14%
GTHX 0.23%
GUTS -5.08%
GXGXW 41.67%
GYRE -8.47%
HALO -1.07%
HARP 0.09%
HCWB -3.75%
HEPA -4.09%
HGEN -84.62%
HILS 5.66%
HLVX 0.00%
HOOK 2.32%
HOTH -3.51%
HOWL -2.35%
HRMY 1.91%
HRTX 3.93%
HSTO 0.00%
HUMA 0.77%
HUMAW -0.01%
IBRX -4.13%
ICCC 0.22%
ICPT 0.21%
ICU 19.15%
ICUCW 20.46%
ICVX -0.91%
IDRA -23.04%
IDYA -1.61%
IFRX -1.54%
IGMS -0.29%
IKNA 0.89%
IKT 0.70%
IMAB 2.03%
IMCR -2.96%
IMGN 0.02%
IMGO 0.00%
IMMP 4.75%
IMMX -7.76%
IMNM 1.00%
IMNN 0.88%
IMPL -27.27%
IMRA 15.96%
IMRN -1.18%
IMRX 0.00%
IMTX -0.75%
IMTXW 6.00%
IMUX 1.85%
IMV 0.00%
IMVT -4.76%
INAB -0.56%
INBX 0.76%
INCY -1.25%
INDP 11.07%
INFI -52.38%
INKT -0.01%
INM 3.14%
INMB 1.68%
INO -1.30%
INSM -1.26%
INTS -2.75%
INVA 0.53%
INZY 0.69%
IOBT -11.11%
IONS 0.81%
IOVA -2.96%
IPA -0.49%
IPHA 5.58%
IPSC -2.34%
IRON -1.64%
ISEE 0.38%
ITOS -1.71%
ITRM 1.67%
IVA 6.96%
IVVD -2.49%
JAGX 0.79%
JANX -3.70%
JAZZ -0.47%
JNCE 0.00%
JSPR -6.17%
JSPRW 20.88%
JUNS 0.00%
JUNSW 0.00%
KA -3.54%
KALV -5.37%
KDNY 0.22%
KMPH -0.34%
KNSA -2.06%
KNTE -0.38%
KOD -6.31%
KPRX 0.96%
KPTI -5.05%
KRBP -10.00%
KRON 0.58%
KROS -1.10%
KRRO -8.11%
KRTX 0.03%
KRYS -0.25%
KTRA 9.02%
KTTA -6.79%
KTTAW 0.92%
KURA -0.29%
KYMR -3.14%
KYTX -4.13%
KZIA 2.65%
KZR -0.85%
LABP 0.57%
LBPH -1.18%
LBPS 0.00%
LBPSW 14.81%
LEGN 1.82%
LENZ -4.83%
LEXX 0.78%
LEXXW -14.63%
LGND -0.50%
LGNDV 0.00%
LGVN -7.71%
LIAN -8.28%
LIFE 2.70%
LIPO -3.87%
LIXT -5.24%
LIXTW 63.57%
LJPC -0.32%
LMNL 0.12%
LOGC 1.39%
LPCN -1.86%
LPTX -2.72%
LQDA -0.16%
LRMR -1.56%
LSTA -4.06%
LTRN 1.37%
LUMO -1.32%
LVTX -1.03%
LXEO -2.79%
LXRX -1.76%
LYEL -36.03%
LYRA 1.16%
MACK 0.10%
MBIO -10.02%
MBRX -1.72%
MCRB 3.17%
MDGL -0.88%
MDNA -13.16%
MDWD -0.34%
MDXG -2.80%
MEIP 1.40%
MESO -1.41%
MGNX -2.45%
MGTA -7.74%
MGTX -3.57%
MGX -4.01%
MIRM -1.18%
MIRO 0.59%
MIST 1.15%
MITO 0.00%
MLEC -7.69%
MLECW 2.31%
MLND -5.36%
MLTX 0.71%
MLYS -7.52%
MNKD 0.29%
MNMD -0.07%
MNOV 2.11%
MNPR -8.52%
MOLN 1.79%
MOR 1.20%
MORF -3.40%
MREO -2.71%
MRKR 2.57%
MRNA -5.98%
MRNS -4.04%
MRSN -2.38%
MRTX -0.17%
MRUS 0.29%
MRVI -1.16%
MTCR -1.29%
MTEM 4.46%
MTP -18.50%
MURA -0.93%
MYMD 5.46%
NAMS 2.94%
NAMSW -0.21%
NAUT 1.55%
NBRV 0.71%
NBSE -1.56%
NBTX 12.09%
NCNA 0.73%
NERV -0.63%
NEXI 4.04%
NGM -1.28%
NGNE -1.59%
NKGN 10.14%
NKGNW 8.00%
NKTR -4.21%
NKTX -5.38%
NLSP 5.35%
NLSPW 26.67%
NMRA -3.14%
NMTR -42.97%
NOVN -24.84%
NRBO 9.47%
NRIX -2.14%
NRSN -5.12%
NRSNW 0.00%
NRXP -3.75%
NRXPW 18.33%
NRXS 4.82%
NTBL 3.42%
NTEC -12.45%
NTHI 0.00%
NTLA -6.89%
NTRBW -31.07%
NUVL -1.69%
NVAX -2.50%
NVCT 3.55%
NVIV -34.28%
NXTC -2.94%
NYMX -0.05%
OABI 1.45%
OABIW -10.06%
OBIO -3.07%
OBSV 0.00%
OCEA 0.00%
OCGN 2.97%
OCS -1.00%
OCUL -0.08%
OCUP 1.84%
ODT -4.27%
OKYO 1.51%
OLMA -5.12%
OMER -1.03%
OMGA 5.64%
ONCO 4.54%
ONCR -3.08%
ONCS 31.87%
ONCT -3.05%
ONCY 1.49%
ONTX -0.47%
ONVO 0.47%
OPNT 0.00%
OPT 3.09%
ORGS 0.96%
ORIC -3.55%
ORMP 18.22%
ORPH 0.00%
ORTX 0.30%
OSMT -1.77%
OTIC -92.64%
OTLK -2.22%
OVID 0.28%
OYST 0.00%
PALI 1.30%
PASG -1.30%
PBLA -7.50%
PBM -3.48%
PBYI 1.52%
PCSA 0.00%
PCVX -0.23%
PDSB -4.58%
PEPG 0.78%
PGEN -2.99%
PHAR 1.51%
PHAS 0.00%
PHAT -1.06%
PHIO -0.83%
PHIOW 36.47%
PHVS -7.32%
PHXM -5.20%
PIRS 0.58%
PKBO 0.00%
PKBOW 999 900.00%
PLRX -1.47%
PLUR 7.39%
PMN 0.72%
PMVP -0.30%
PNT 0.16%
PPBT -5.61%
PRAX 3.19%
PRDS 0.93%
PRLD -2.37%
PROG -3.47%
PROK 0.37%
PRQR -0.66%
PRTA -2.36%
PRTC 0.49%
PRTG 7.02%
PRTK 1.83%
PRVB 0.00%
PSTI -2.91%
PSTV -10.45%
PSTX -1.36%
PTCT -0.18%
PTE -0.82%
PTGX -0.91%
PTIXW -48.41%
PULM 2.60%
PXMD 4.76%
PYPD 0.07%
PYXS 1.14%
QLGN -3.00%
QNCX 5.70%
QNRX -1.34%
QSI -11.59%
QSIAW -3.13%
QTTB -3.45%
QURE -0.79%
RAIN -1.63%
RANI 6.42%
RAPT -0.97%
RARE 1.27%
RCKT -8.68%
REGN 0.17%
RENB -3.41%
REPL -2.15%
RETA 0.02%
REUN -0.89%
REVB -2.79%
REVBU 3.46%
REVBW 4.38%
RGLS -6.78%
RGNX -5.56%
RIGL -3.29%
RLAY -3.56%
RLMD 0.35%
RLYB -1.01%
RNA 0.51%
RNAC -2.94%
RNAZ -1.90%
RNXT 0.89%
ROIV -1.94%
ROIVW 4.56%
RPHM 0.00%
RPRX 0.28%
RPTX 0.15%
RUBY 2.70%
RVLP -32.05%
RVMD -0.90%
RVMDW -30.00%
RVNC 0.21%
RVPH -2.38%
RVPHW 1.62%
RXDX 0.09%
RXRX -4.90%
RYTM -5.19%
RYZB 0.02%
RZLT 3.93%
SABS -1.37%
SABSW -11.81%
SAGE 1.19%
SANA -3.69%
SAVA -0.16%
SAVAW 0.00%
SBBP 1.52%
SBTX 1.03%
SCNI -0.06%
SCPH 5.30%
SCPS 0.00%
SEEL -4.12%
SEER 0.29%
SELB -8.00%
SESN 7.29%
SGEN -0.07%
SGMO -1.30%
SGMT -2.18%
SGTX -2.56%
SIOX 22.63%
SLDB -9.33%
SLGL 4.12%
SLN -4.57%
SLNO -4.44%
SLRX 5.26%
SLS -1.71%
SMMT -1.75%
SNDX 1.33%
SNGX -4.91%
SNPX -4.44%
SONN -0.01%
SPPI -0.49%
SPRB 0.63%
SPRC -2.75%
SPRO 0.05%
SRNE -34.00%
SRPT -0.85%
SRRA 0.00%
SRRK -1.98%
SRZN -2.45%
STAB 0.00%
STOK -5.56%
STRO -3.85%
STSA 0.00%
STTK -1.69%
SURF -0.93%
SVRA -7.50%
SWTX -0.39%
SYBX -1.29%
SYRS -1.55%
TALS -0.73%
TARA -7.62%
TARS 0.45%
TBPH 0.60%
TCBP 2.48%
TCDA 0.00%
TCON 2.46%
TCRR 0.00%
TCRT 0.08%
TCRX -1.05%
TECH -0.19%
TENX 1.91%
TERN -8.13%
TFFP -5.33%
TGTX -4.22%
THRX 0.12%
TIL -1.09%
TLC 0.00%
TLSA -4.60%
TNGX -3.08%
TNXP -6.00%
TNYA -4.91%
TPST 5.11%
TRDA -4.06%
TRVI 2.30%
TRVN 6.50%
TSHA -22.31%
TSVT -2.93%
TTNP -7.66%
TVTX 1.13%
TYRA -8.54%
UBX -2.48%
UNCY -4.00%
URGN -1.15%
UTHR 0.61%
VACC 11.36%
VALN -4.07%
VAXX 100.00%
VBIV 0.33%
VBLT -8.77%
VCEL 0.74%
VCNX 10.35%
VCYT -1.34%
VERA -3.92%
VERU 0.97%
VERV -3.06%
VIGL 4.84%
VINC 2.28%
VIR 1.08%
VIRI -1.85%
VIRX 3.15%
VKTX -1.23%
VLON -13.04%
VNDA -3.50%
VOR -2.41%
VRCA -0.28%
VRDN -4.39%
VRNA -0.80%
VRPX 0.38%
VRTX 0.32%
VSTM -0.85%
VTGN -0.45%
VTVT -2.97%
VTYX -1.05%
VXRT -4.25%
VYGR -0.38%
VYNE -4.62%
VYNT 7.78%
WINT 2.18%
WVE -6.19%
XBIO 1.03%
XBIT -2.92%
XCUR 3.55%
XENE -1.38%
XERS 2.62%
XFOR 4.69%
XLO 3.94%
XLRN 0.00%
XNCR 0.62%
XOMA -2.85%
XOMAO -0.16%
XOMAP -0.82%
XRTX -8.00%
YMAB -1.80%
ZGNX 0.00%
ZIOP -0.88%
ZLAB -2.65%
ZNTL -2.38%
ZSAN 0.00%
相关性 (AI algo v.1.1b): Overvalued: -0.53% $0.0401 paired level. (算法实时跟踪最相关股票的变化并提供即时更新)

NLS Pharmaceutics AG 相关性

10 最正相关
10 最负相关

你知道吗?

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。

相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

NLS Pharmaceutics AG 财务报表

Annual 2023
营收: $0
毛利润: $-11 408.00 (0.00 %)
EPS: $-0.320
FY 2023
营收: $0
毛利润: $-11 408.00 (0.00 %)
EPS: $-0.320
FY 2022
营收: $0
毛利润: $-11 408.00 (0.00 %)
EPS: $-0.840

Financial Reports:

No articles found.

NLS Pharmaceutics AG Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

NLS Pharmaceutics AG

NLS Pharmaceutics AG, a clinical-stage biopharmaceutical company, engages in the discovery and development of therapies for patients with rare and complex central nervous system disorders. The company is focusing on the development of treatments for narcolepsy, idiopathic hypersomnia, and other rare sleep disorders, as well as neurodevelopmental disorders, such as attention deficit hyperactivity disorder (ADHD). Its lead product candidates include Quilience to treat excessive daytime sleepiness and cataplexy; and Nolazol for the treatment of ADHD. The company also developing NLS-4, a selective dopamine reuptake inhibitor to prevent rare sleep disorders; NLS-3, a repurposed reverse ester of methylphenidate for treatment of ADHD; NLS-8, a melatonin ML1A receptor agonist, improved scopolamine-induced amnesia; NLS-11, a norepinephrine and dopamine reuptake inhibitor and muscarinic M1, M2, M3 receptor antagonist; and NLS-12, a norepinephrine and dopamine reuptake inhibitor and muscarinic M4 receptor antagonist. NLS Pharmaceutics AG was incorporated in 2015 and is based in Zurich, Switzerland.

关于 实时信号

此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。

实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。

Total Execution Time: 1.2772290706635 seconds
Number of API calls: 3
Number of DB calls: 9